Status:
ENROLLING_BY_INVITATION
Treatment of Residual Hypermetropic Refraction on Young Patients After LASIK Using Human Fresh Corneal Lenticule Implantation With ReLEX Smile Surgery
Lead Sponsor:
Eye Hospital Pristina Kosovo
Conditions:
Refractive Errors
Eligibility:
All Genders
20-45 years
Phase:
NA
Brief Summary
LASIK (laser-assisted in situ keratomileusis) is a type of refractive surgery for correction of myopia, hyperopia and astigmatism. Yet approximately 30% of operated patients have symptoms like glare, ...
Detailed Description
The main problem at young patients post - LASIK after one year is residual refractive errors. The method used in Eye Hospital is treatment with implantation of human fresh corneal lenticule (min. -1....
Eligibility Criteria
Inclusion
- residual hypermetropic refraction,
- low visual acuity
Exclusion
- active anterior segment pathology,
- glaucoma,
- retinae detachment,
Key Trial Info
Start Date :
January 8 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
November 8 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT04793893
Start Date
January 8 2019
End Date
November 8 2025
Last Update
February 20 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Eye Hospital Pristina
Pristina, Kosovo, 10000